Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

导出原文传递

翻译打印收藏纠错

作者： Drilon, Alexander ^[1] ; Rekhtman, Natasha ^[2] ; Arcila, Maria ^[3] ; Wang, Lu ^[4] ; Ni, Andy ; Albano, Melanie ; Van Voorthuysen, Martine ; Somwar, Romel ; Smith, Roger S. ; Montecalvo, Joseph ; Plodkowski, Andrew ; Ginsberg, Michelle S. ; Riely, Gregory J. ; Rudin, Charles M. ; Ladanyi, Marc ; Kris, Mark G.

作者单位： Mem Sloan Kettering Canc Ctr, Dept Radiol, Weill Cornell Med, 1275 York Ave, New York, NY 10021 USA ^[1] Mem Sloan Kettering Canc Ctr, Dept Med, Weill Cornell Med, Thorac Oncol Serv,Div Solid Tumor Oncol ^[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Weill Cornell Med, New York, NY 10021 USA ^[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Weill Cornell Med, 1275 York Ave, New York, NY 10021 USA ^[4]

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

The lancet oncology

2016年17卷12期

1653-1660页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

The lancet oncology

相似文献

The lancet oncology

相关期刊

检索历史清除